ArticleInternational journal of retina and vitreous2021

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.

Mohamed A Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.